Nomenclature
CAS number: 457-60-3
Sulfoxylic acid mono[[[5-[(3-amino-4-hydroxyphenyl)diarsenyl]-2-hydroxyphenyl]amino]methyl]
ester monosodium salt; [5-[(3-amino-4-hydroxyphenyl)arseno]-2-hydroxyanilino]methanol
sulfoxylate sodium; arsphenamine methylenesulfoxylic acid sodium salt; 3,3′-diamino-4,4′-dihydroxyarsenobenzenemethylenesulfoxylate
sodium; Neosalvarsan (Hoechst); Collunovar; N.A.B.; Neo-Arsoluin; Vetarsenobillon; Novarsenobillon; Arsevan; Novarsan; Novarsenobenzol; Miarsenol.
C
13H
13As
2N
2NaO
4S; mol wt 466.15.
C 33.50%, H 2.81%, As 32.14%, N 6.01%, Na 4.93%, O 13.73%, S
6.88%.
Description and references
Medicinal grade contains a small amount of
inert inorganic salts and some solvent. The National Formulary requires 19+% As. Prepn from arsphenamine + sodium formaldehydesulfoxylate:
Krumwiede, J. Am. Pharm. Assoc. 8, 795 (1919); Heyl, Miller, ibid. 11, 432 (1922); Dohr, US 1549465 (1925); Kober, US 1564859 (1926); Kraft et al., SU 158388 (1962). Physicochemical properties and toxicity: H. N.
Wright et al., J. Pharmacol. Exp.
Ther. 73, 12 (1941).
Properties
Yellow powder; odorless or slight odor. Oxidizes
in air, becoming darker and more toxic; higher temps accelerate the
oxidation; hence marketed in air-evacuated ampuls or filled with a
nonoxidizing gas. Very sol in water; sol in glycerol. Slightly sol
in alcohol or acetone. Practically insol in chloroform, ether. Its
aq soln is practically neutral, unlike arsphenamine, which is acid.Therapeutic Category (Veterinary)
Has been used in contagious pleuropneumonia,
babesiasis, equine petechial fever, eperythrozoonosis.